2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Drug Eluting Stent Market?

The escalating prevalence of coronary heart disease is predicted to boost the expansion of the drug-eluting stent market. Coronary heart disease, characterized by the narrowing or blockage of coronary arteries due to plaque accumulation, can result in serious complications, including heart attacks and chest discomfort. Sedentary lifestyles, unhealthy food habits, aging demographics, and enhanced consciousness are contributing to the rise of this condition. Drug-eluting stents play a critical role in treating coronary heart disease, effectively unblocking or widening the constricted arteries, and dispensing medicine that prevents artery re-constriction, or restenosis. As an example, in May 2024, data from the Centers for Disease Control and Prevention, a US governmental entity, showed the prevalence of coronary heart disease among adults 18 and older had risen from 4.6% in 2020 to 4.9% in 2022. The growing prevalence of coronary heart disease is anticipated to further drive the expansion of the drug-eluting stent market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

#What Long-Term Growth Rate is Expected for theDrug Eluting Stent Market Between 2025 and 2034?

The market size for drug-eluting stents has experienced robust growth in the past few years. Its valuation is anticipated to rise from $7.63 billion in 2024 to about $8.29 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.6%. The growth during the historical period can be linked to several factors, including the requirement for enhanced treatment alternatives, clinical evidence supporting its use, approval from regulatory bodies, prevailing healthcare economics, and established guidelines and recommendations.

The market for drug eluting stents is projected to witness robust expansion in the coming years, escalating to $11.37 billion by 2029 with an 8.2% compound annual growth rate (CAGR). The surge expected in the forecast period is due to factors such as the increase in the aging population and chronic diseases burden, widening of indications, modifications in healthcare reimbursement policies, expansion of the global market, and focus on patient-centric care. Leading trends anticipated within this forecast period encompass personalized medical approaches, minimally invasive procedures, the emergence of innovative healthcare technologies, and cutting-edge drug formulations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557

What New Market Trends Are Reshaping theDrug Eluting Stent Market and Its Opportunities?

Firms involved in the drug-eluting stent market are concentrating on the creation of novel delivery systems, including dual-layer balloons, to enhance patient results and push forward the intersessional cardiology sector. A dual-layer balloon in this type of system increases the accuracy of drug delivery and stent deployment by promoting superior control and evenly distributing the drug across the arterial wall. For instance, Medtronic Plc, a medical supply company based in Ireland, in August 2022, introduced Onyx Frontier, its newest generation of drug-eluting coronary stent systems. These new devices augment delivery mechanisms by utilizing the successful results and clinical data from the preceding version, Resolute Onyx DES. The Onyx Frontier DES relies on the same top-rated stent platform as its predecessor, offering a wide range of sizes to accommodate patients with diameters between 2.0mm and 5.0mm. Notable improvements of the Onyx Frontier DES include a revolutionary dual-layer balloon, a reduced crossing profile, and enhanced catheter flexibility. These enhancements result in a 16% boost in deliverability when compared to the previous generation, the Resolute Onyx DES, without compromising radial strength.

Who Are the Leading Market Players Fueling Growth in the Drug Eluting Stent Market Trend?

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

How is the Global Drug Eluting Stent Market Segemented?

The drug eluting stent market covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

Which Geographics are Influencing the Growth of the Drug Eluting Stent Market?

North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Drug Eluting Stent Market 2025, By The Business Research Company:

Consumer Electronics Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/consumer-electronics-repair-and-maintenance-global-market-report

Authorized Car Service Center Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/authorized-car-service-center-global-market-report

Maintenance Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: